This 16 April 2020 video from the USA says about itself:
It’s definitely just a coincidence that one of Trump‘s coronavirus task force members is a former lobbyist for Gilead Sciences, the company that won orphan drug status for its COVID-19 treatment.
From Project Syndicate/New York in the USA, Sunday, April 26, 2020:
Patents vs. the pandemic
Joseph E. Stiglitz, Arjun Jayadev and Achal Prabhala
Imagine a world in which a global network of medical professionals monitored for emerging strains of a contagious virus, periodically updated an established formula for vaccinating against it, and then made that information available to companies and countries around the world. Moreover, imagine if this work were done without any intellectual-property (IP) considerations, and without pharmaceutical monopolies exploiting a desperate public to maximize their profits.
This may sound like a utopian…
View original post 1,005 more words